Repros Therapeutics (RPRX) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $56.45 --0%
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
CCEL, FNGR, FAST, More
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.31), $0.03 better than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup (C) Tops Q2 EPS by 42c
- Ligand completes $739M acquisition of XOMA Royalty
- Wells Fargo (WFC) Tops Q2 EPS by 28c, Beats on Revene
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
